scholarly journals Neuroprotective expression of turmeric and curcumin

Food Research ◽  
2020 ◽  
Vol 4 (6) ◽  
pp. 2366-2381
Author(s):  
S. Abbas ◽  
M.S. Latif ◽  
N.S. Shafie ◽  
M.I. Ghazali ◽  
F. Kormin

Turmeric (Curcuma longa) is extensively used as a spice and a coloring agent in Southeast Asia. Turmeric is used as a traditional remedy for cough, diabetic wounds, hepatic disorders, and rheumatism due to its antiseptic, antibacterial, and anti-inflammatory properties. Since the last few decades, extensive work has been done on turmeric and its constituents to explore its pharmacological actions. Curcumin is the main constituent of turmeric and is well demonstrated for its anti-inflammatory, hypoglycaemic, antioxidant, wound-healing, and antimicrobial activities. The functional neurons of the brain and synapses are lost in neurodegenerative disorders for which there is no permanent cure. Oxidative damage and inflammation play a role in age-related neurological disorders. The antioxidants have the ability to prevent different neurological disorders. Recent studies have shown that both turmeric and curcumin possess neuroprotective and cognitiveenhancing properties that help to prevent neurodegenerative diseases like Alzheimer's disease and Parkinson’s disease. Different experimental studies have indicated the antioxidant and anti-ageing properties of turmeric and curcumin. Various studies have shown that curcumin acts as a strong barrier against neurological disorders and, hence, it may be a potential drug candidate for the prevention of neurodegenerative diseases. The aim of this review was to present the current pieces of evidence in the literature regarding the neuroprotective effects of turmeric and curcumin.

Author(s):  
Ramin Ahangar-Sirous ◽  
Mohadeseh Poudineh ◽  
Arina Ansari ◽  
Ali Nili ◽  
Seyyed Mohammad Matin Alavi Dana ◽  
...  

: Age-related neurological disorders [ANDs] involve neurodegenerative diseases [NDDs] such as Alzheimer's disease [AD], the most frequent kind of dementia in elderly people, and Parkinson's disease [PD], and also other disorders like epilepsy and migraine. Although ANDs are multifactorial, Aging is a principal risk factor for them. The common and most main pathologic features among ANDs are inflammation, oxidative stress, and misfolded proteins accumulation. Since failing brains caused by ANDs impose a notable burden on public health and their incidence is increasing, a lot of works has been done to overcome them. Garlic, Allium sativum, has been used for different medical purposes globally and more than thousands of publications have reported its health benefits. Garlic and aged garlic extract are considered potent anti-inflammatory and antioxidants agents and can have remarkable neuroprotective effects. This review is aimed to summarize knowledge on the pharmacotherapeutic potential of garlic and its components in ANDs.


2020 ◽  
Vol 2020 ◽  
pp. 1-14 ◽  
Author(s):  
Rabia Shabir Ahmad ◽  
Muhammad Bilal Hussain ◽  
Muhammad Tauseef Sultan ◽  
Muhammad Sajid Arshad ◽  
Marwa Waheed ◽  
...  

Turmeric (Curcuma longa L.) is a popular natural drug, traditionally used for the treatment of a wide range of diseases. Its root, as its most popular part used for medicinal purposes, contains different types of phytochemicals and minerals. This review summarizes what is currently known on biochemistry, safety, pharmacological activities (mechanistically), and clinical applications of turmeric. In short, curcumin is considered as the fundamental constituent in ground turmeric rhizome. Turmeric possesses several biological activities including anti-inflammatory, antioxidant, anticancer, antimutagenic, antimicrobial, antiobesity, hypolipidemic, cardioprotective, and neuroprotective effects. These reported pharmacologic activities make turmeric an important option for further clinical research. Also, there is a discussion on its safety and toxicity.


2021 ◽  
Vol 8 ◽  
Author(s):  
Maja Milošević ◽  
Aleksandra Arsić ◽  
Zorica Cvetković ◽  
Vesna Vučić

Healthcare systems worldwide are seriously challenged by a rising prevalence of neurodegenerative diseases (NDDs), which mostly, but not exclusively, affect the ever-growing population of the elderly. The most known neurodegenerative diseases are Alzheimer's (AD) and Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis, but some viral infections of the brain and traumatic brain injury may also cause NDD. Typical for NDD are the malfunctioning of neurons and their irreversible loss, which often progress irreversibly to dementia and ultimately to death. Numerous factors are involved in the pathogenesis of NDD: genetic variability, epigenetic changes, extent of oxidative/nitrosative stress, mitochondrial dysfunction, and DNA damage. The complex interplay of all the above-mentioned factors may be a fingerprint of neurodegeneration, with different diseases being affected to different extents by particular factors. There is a voluminous body of evidence showing the benefits of regular exercise to brain health and cognitive functions. Moreover, the importance of a healthy diet, balanced in macro- and micro-nutrients, in preventing neurodegeneration and slowing down a progression to full-blown disease is evident. Individuals affected by NDD almost inevitably have low-grade inflammation and anomalies in lipid metabolism. Metabolic and lipid profiles in NDD can be improved by the Mediterranean diet. Many studies have associated the Mediterranean diet with a decreased risk of dementia and AD, but a cause-and-effect relationship has not been deduced. Studies with caloric restriction showed neuroprotective effects in animal models, but the results in humans are inconsistent. The pathologies of NDD are complex and there is a great inter-individual (epi)genetic variance within any population. Furthermore, the gut microbiome, being deeply involved in nutrient uptake and lipid metabolism, also represents a pillar of the gut microbiome–brain axis and is linked with the pathogenesis of NDD. Numerous studies on the role of different micronutrients (omega-3 fatty acids, bioactive polyphenols from fruit and medicinal plants) in the prevention, prediction, and treatment of NDD have been conducted, but we are still far away from a personalized diet plan for individual NDD patients. For this to be realized, large-scale cohorts that would include the precise monitoring of food intake, mapping of genetic variants, epigenetic data, microbiome studies, and metabolome, lipidome, and transcriptome data are needed.


2020 ◽  
Author(s):  
Laura Casares ◽  
Juan Diego Unciti ◽  
Maria Eugenia Prados ◽  
Diego Caprioglio ◽  
Maureen Higgins ◽  
...  

ABSTRACTOxidative stress and inflammation in the brain are two key hallmarks of neurodegenerative diseases (NDs) such as Alzheimer’s, Parkinson’s, Huntington’s and multiple sclerosis. The axis NRF2-BACH1 has anti-inflammatory and anti-oxidant properties that could be exploited pharmacologically to obtain neuroprotective effects. Activation of NRF2 or inhibition of BACH1 are, individually, promising therapeutic approaches for NDs. Compounds with dual activity as NRF2 activators and BACH1 inhibitors, could therefore potentially provide a more robust antioxidant and anti-inflammatory effects, with an overall better neuroprotective outcome. The phytocannabinoid cannabidiol (CBD) inhibits BACH1 but lacks significant NRF2 activating properties. Based on this scaffold, we have developed a novel CBD derivative that is highly effective at both inhibiting BACH1 and activating NRF2. This new CBD derivative provides neuroprotection in cell models of relevance to Huntington’s disease, setting the basis for further developments in vivo.


Molecules ◽  
2021 ◽  
Vol 27 (1) ◽  
pp. 236
Author(s):  
Tarek Benameur ◽  
Giulia Giacomucci ◽  
Maria Antonietta Panaro ◽  
Melania Ruggiero ◽  
Teresa Trotta ◽  
...  

Curcumin, the dietary polyphenol isolated from Curcuma longa (turmeric), is commonly used as an herb and spice worldwide. Because of its bio-pharmacological effects curcumin is also called “spice of life”, in fact it is recognized that curcumin possesses important proprieties such as anti-oxidant, anti-inflammatory, anti-microbial, antiproliferative, anti-tumoral, and anti-aging. Neurodegenerative diseases such as Alzheimer’s Diseases, Parkinson’s Diseases, and Multiple Sclerosis are a group of diseases characterized by a progressive loss of brain structure and function due to neuronal death; at present there is no effective treatment to cure these diseases. The protective effect of curcumin against some neurodegenerative diseases has been proven by in vivo and in vitro studies. The current review highlights the latest findings on the neuroprotective effects of curcumin, its bioavailability, its mechanism of action and its possible application for the prevention or treatment of neurodegenerative disorders.


2018 ◽  
Vol 2018 ◽  
pp. 1-12 ◽  
Author(s):  
Yingjuan Ma ◽  
Bin Ma ◽  
Yuying Shang ◽  
Qingqing Yin ◽  
Dejie Wang ◽  
...  

Aging is a major factor that contributes to neurological impairment and neuropathological changes, such as inflammation, oxidative stress, neuronal apoptosis, and synaptic dysfunction. Flavonoids act as protective antioxidant and anti-inflammatory agents against various age-related neurodegenerative diseases. Here, we investigated the protective effect and mechanisms of the flavonoid-rich ethanol extract from the leaves of Diospyros kaki (FELDK) in the cortex and hippocampus of D-galactose- (gal-) aged mice. Our results showed that FELDK treatment restored memory impairment in mice as determined by the Y-maze and Morris water maze tests. FELDK decreased oxidative stress levels via inhibiting reactive oxygen species (ROS) and malondialdehyde (MDA) production and elevating antioxidative enzymes. FELDK also alleviated D-gal-induced neuroinflammation via suppressing the expression of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) and activating microgliosis and astrocytosis, nuclear factor kappa B (NF-κB) nuclear translocation, and downstream inflammatory mediators. Moreover, FELDK inhibited the phosphatidylinositol 3-kinase (PI3K)/Akt and C-jun N-terminal kinase (JNK) apoptotic signaling pathways and ameliorated the impairment of synapse-related proteins. Hence, these results indicate that FELDK exerts neuroprotective effects on D-gal-induced brain aging. Thus, FELDK may be a potential therapeutic strategy for preventing and treating age-related neurodegenerative diseases such as Alzheimer’s disease.


Planta Medica ◽  
2018 ◽  
Vol 85 (01) ◽  
pp. 48-55 ◽  
Author(s):  
Yu Lei ◽  
Peng Fu ◽  
Xie Jun ◽  
Peng Cheng

AbstractGeraniol is an acyclic isoprenoid monoterpene isolated from the essential oils of aromatic plants including Cinnamomum tenuipilum, Valeriana officinalis, and several other plants. The limited source of geraniol from plant isolation cannot fulfill the great demand from the flavor and fragrance industries, which require maximizing geraniol production through biotechnology processes. The diverse activities of geraniol suggested that geraniol could treat various diseases as a promising drug candidate. In order to evaluate the potential of geraniol applied in a clinical trial, this review aims at providing a comprehensive summary of the pharmacological effects of geraniol. The publications retrieved from PubMed, ScienceDirect, Springer, and Wiley databases were collected and summarized for the last 6 years. Then, the potential application of geraniol as a drug is discussed based on its pharmacological properties, including antitumor, anti-inflammatory, antioxidative, and antimicrobial activities, and hepatoprotective, cardioprotective, and neuroprotective effects. Hence, this review aims at providing evidence of the pharmacological activities of geraniol in the context of further development as a drug candidate in clinical application.


2007 ◽  
Vol 3 (3) ◽  
pp. 245-253 ◽  
Author(s):  
Kelly R. Miller ◽  
Wolfgang J. Streit

AbstractNeuroinflammation resulting from chronic reactive microgliosis is thought to contribute to age-related neurodegeneration, as well as age-related neurodegenerative diseases, specifically Alzheimer's disease (AD). Support of this theory comes from studies reporting a progressive, age-associated increase in microglia with an activated phenotype. Although the underlying cause(s) of this microglial reactivity is idiopathic, an accepted therapeutic strategy for the treatment of AD is inhibition of microglial activation using anti-inflammatory agents. Although the effectiveness of anti-inflammatory treatment for AD remains equivocal, microglial inhibition is being tested as a potential treatment for additional neurodegenerative disorders including amyotrophic lateral sclerosis and Parkinson's disease. Given the important and necessary functions of microglia in normal brain, careful evaluation of microglial function in the aged brain is a necessary first step in targeting more precise treatment strategies for aging-related neurodegenerative diseases. Studies from our laboratory have shown multiple age-related changes in microglial morphology and function that are suggestive of cellular senescence. In this manuscript, we review current knowledge of microglia in the aging brain and present new, unpublished work that further supports the theory that microglia experience an age-related decline in proliferative function as a result of cellular senescence.


2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 1335.1-1335
Author(s):  
I. Bashkova ◽  
I. Madyanov ◽  
K. Misko ◽  
E. Preobrazhenskaia

Background:Genetic, biochemical, metabolic, hormonal (primarily imbalance of sex hormones) factors are involved in the progression of osteoarthritis (OA). Dehydroepiandrosterone and its metabolite, dehydroepiandrosterone sulfate (DHEA-S), have a stress-limiting, anti-atherogenic, anti-diabetic, antihypertensive, anti-infective, immunomodulatory effects. Heroprotective effect is not excluded. Experimental studies have identified a relationship between an age-related decrease in DHEA-S levels and various adverse effects of aging.Objectives:To identify the contribution of DHEA-S to the pathogenesis of OA, it`s advisable to conduct a comparative analysis of connection of the adrenal hormones with clinical, laboratory, radiological signs of the course of OA.Methods:Patients with primary OA with a lesion of the knee joints (n=90, including 22 men) were examined. The age of the patients - 29-69 years, the duration of the disease – 1.5-20 years. The control group (n=114, including 26 men) was formed by random sampling of the population from healthy people, it`s representative by gender and age. We investigated the serum levels of cortisol, DHEA-S, estradiol (in women), testosterone (in men) and carried out radiography of the knee joints. OA was diagnosed using R.D. Althman, the x-ray stage-according to the classification of Kellgren and Lawrence. Statistically determined the mean value, standard deviation. Differences between the samples were considered statistically significant at p<0.05. To create a model of OA pathogenesis, the method of principal components of factor analysis was used.Results:The DHEA-S level in the blood of patients with OA was lower than that of the control group (2.40±1.20 vs 3.66±1.45 μg/ml, p=0.001),in women-was lower, than in men (2.25±1.17 vs 2.89±1.23 μg/ml, p=0.045). In the control group, gender differences were not statistically significant (p>0.05). All patients with OA showed an inverse correlation between age and DHEA-S (r=-0.511, p=0.0001, and r=-0.549, p=0.0001 respectively). For factor analysis the most important signs for the course of OA are ESR levels, C-reactive protein (CRP) in the blood (as markers of inflammatory component of OA, or factor 2) were selected, and the radiological stage of OA (degenerative component, or factor 1). In women, we regarded factor 1 as «degenerative», the maximum contribution to total dispersion was made by the «x-ray stage» (+0.72). This symptom was opposed by the «DHEA-S level» (-0.79) and «estradiol blood level» (-0.68), which suggests a link between degenerative and dystrophic processes in the knee joint in women with OA and a decrease in blood levels of DHEA-S and estradiol. Factor 2 we interpreted as «inflammatory». This was indicated by the values of «CRP» (+0.66) and «ESR» (+0.64). The «inflammatory» factor in women from hormonal indicators was opposed by the «blood cortisol content» (-0.31) and «DHEA-S level» (-0.26). Factor 1 in men accounted for 46% of the total variance. Since factor 1 in men included the most significant «CRP» (+0.85), «X-ray stage» (+0.77) and «ESR» (+0.72), we called it «antidegenerative anti-inflammatory factor». The maximum value (modulo) in factor 1 is for DHEA-S (-0.76) and the lower is for testosterone (-0.53). So, in men, a sufficient level of DHEA-S is closely related to the «antidegenerative-anti-inflammatory» factor of OA pathogenesis and DHEA-S counteracts 2 key pathogenetic processes simultaneously-degenerative and inflammatory.Conclusion:In women, a decrease in DHEA-S is a risk factor for the predominantly degenerative component of OA, in men it`s a universal risk factor, predisposing both to the development of inflammation and degenerative changes in the jointsDisclosure of Interests:None declared.


2021 ◽  
Vol 13 ◽  
Author(s):  
Anna Gasiorowska ◽  
Malgorzata Wydrych ◽  
Patrycja Drapich ◽  
Maciej Zadrozny ◽  
Marta Steczkowska ◽  
...  

The elderly population is growing worldwide, with important health and socioeconomic implications. Clinical and experimental studies on aging have uncovered numerous changes in the brain, such as decreased neurogenesis, increased synaptic defects, greater metabolic stress, and enhanced inflammation. These changes are associated with cognitive decline and neurobehavioral deficits. Although aging is not a disease, it is a significant risk factor for functional worsening, affective impairment, disease exaggeration, dementia, and general disease susceptibility. Conversely, life events related to mental stress and trauma can also lead to accelerated age-associated disorders and dementia. Here, we review human studies and studies on mice and rats, such as those modeling human neurodegenerative diseases, that have helped elucidate (1) the dynamics and mechanisms underlying the biological and pathological aging of the main projecting systems in the brain (glutamatergic, cholinergic, and dopaminergic) and (2) the effect of defective glutamatergic, cholinergic, and dopaminergic projection on disabilities associated with aging and neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases. Detailed knowledge of the mechanisms of age-related diseases can be an important element in the development of effective ways of treatment. In this context, we briefly analyze which adverse changes associated with neurodegenerative diseases in the cholinergic, glutaminergic and dopaminergic systems could be targeted by therapeutic strategies developed as a result of our better understanding of these damaging mechanisms.


Sign in / Sign up

Export Citation Format

Share Document